AL-15469A for the Treatment of Bacterial Conjunctivitis.

Trial Profile

AL-15469A for the Treatment of Bacterial Conjunctivitis.

Phase of Trial: Phase III

Latest Information Update: 11 Nov 2017

At a glance

  • Drugs Moxifloxacin (Primary)
  • Indications Bacterial infections; Infectious conjunctivitis
  • Focus Therapeutic Use
  • Sponsors Alcon
  • Most Recent Events

    • 06 Oct 2009 Status changed from active, no longer recruiting to completed as reported by
    • 10 Sep 2007 Status changed from recruiting to in progress.
    • 06 Oct 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top